These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 22653573)

  • 21. Flexible sigmoidoscopy screening for colorectal cancer: uptake in a population-based pilot programme.
    Robb K; Power E; Kralj-Hans I; Edwards R; Vance M; Atkin W; Wardle J
    J Med Screen; 2010; 17(2):75-8. PubMed ID: 20660435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colorectal cancer screening.
    Bretthauer M
    J Intern Med; 2011 Aug; 270(2):87-98. PubMed ID: 21575082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparing different strategies for colorectal cancer screening in Italy: predictors of patients' participation.
    Senore C; Armaroli P; Silvani M; Andreoni B; Bisanti L; Marai L; Castiglione G; Grazzini G; Taddei S; Gasperoni S; Giuliani O; Malfitana G; Marutti A; Genta G; Segnan N
    Am J Gastroenterol; 2010 Jan; 105(1):188-98. PubMed ID: 19826409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
    Tsoi KK; Ng SS; Leung MC; Sung JJ
    Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Uptake of faecal immunochemical test screening among nonparticipants in a flexible sigmoidoscopy screening programme.
    Hol L; Kuipers EJ; van Ballegooijen M; van Vuuren AJ; Reijerink JC; Habbema DJ; van Leerdam ME
    Int J Cancer; 2012 May; 130(9):2096-102. PubMed ID: 21702046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concerns, perceived need and competing priorities: a qualitative exploration of decision-making and non-participation in a population-based flexible sigmoidoscopy screening programme to prevent colorectal cancer.
    Hall N; Birt L; Rees CJ; Walter FM; Elliot S; Ritchie M; Weller D; Rubin G
    BMJ Open; 2016 Nov; 6(11):e012304. PubMed ID: 27836872
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gender differences in utilization of colorectal cancer screening.
    Wardle J; Miles A; Atkin W
    J Med Screen; 2005; 12(1):20-7. PubMed ID: 15814015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of colorectal cancer screening in diverse primary care practices.
    Zimmerman RK; Nowalk MP; Tabbarah M; Grufferman S
    BMC Health Serv Res; 2006 Sep; 6():116. PubMed ID: 16970813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of self-reported colorectal cancer screening behavior from a mixed-mode survey of veterans.
    Partin MR; Grill J; Noorbaloochi S; Powell AA; Burgess DJ; Vernon SW; Halek K; Griffin JM; van Ryn M; Fisher DA
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):768-76. PubMed ID: 18381474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Population characteristics related to colorectal cancer testing in New South Wales, Australia: results from the 45 and Up Study cohort.
    Weber MF; Banks E; Ward R; Sitas F
    J Med Screen; 2008; 15(3):137-42. PubMed ID: 18927096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of colorectal cancer screening programmes using sigmoidoscopy and immunochemical faecal occult blood test.
    Senore C; Hassan C; Regge D; Pagano E; Iussich G; Correale L; Segnan N
    J Med Screen; 2019 Jun; 26(2):76-83. PubMed ID: 30180780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colorectal cancer screening with the addition of flexible sigmoidoscopy to guaiac-based faecal occult blood testing: a French population-based controlled study (Wintzenheim trial).
    Denis B; Gendre I; Aman F; Ribstein F; Maurin P; Perrin P
    Eur J Cancer; 2009 Dec; 45(18):3282-90. PubMed ID: 19665368
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Longitudinal Rates of Colon Cancer Screening Use in Winnipeg, Canada: The Experience of a Universal Health-Care System with an Organized Colon Screening Program.
    Decker KM; Demers AA; Nugent Z; Biswanger N; Singh H
    Am J Gastroenterol; 2015 Dec; 110(12):1640-6. PubMed ID: 26169513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Testing for faecal calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT).
    Hoff G; Grotmol T; Thiis-Evensen E; Bretthauer M; Gondal G; Vatn MH
    Gut; 2004 Sep; 53(9):1329-33. PubMed ID: 15306594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer screening before and after switching to a high-deductible health plan.
    Wharam JF; Galbraith AA; Kleinman KP; Soumerai SB; Ross-Degnan D; Landon BE
    Ann Intern Med; 2008 May; 148(9):647-55. PubMed ID: 18458277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Agreement between self-reported and registered colorectal cancer screening: a meta-analysis.
    Dodou D; de Winter JC
    Eur J Cancer Care (Engl); 2015 May; 24(3):286-98. PubMed ID: 24754544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tailored telephone counselling to increase participation of underusers in a population-based colorectal cancer-screening programme with faecal occult blood test: A randomized controlled trial.
    Denis B; Broc G; Sauleau EA; Gendre I; Gana K; Perrin P
    Rev Epidemiol Sante Publique; 2017 Feb; 65(1):17-28. PubMed ID: 28089385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Screening for colorectal cancer in Italy: 2004 survey.
    Zorzi M; Grazzini G; Senore C; Vettorazzi M
    Epidemiol Prev; 2006; 30(1 Suppl 3):41-50. PubMed ID: 16937845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colorectal cancer screening behavior in women attending screening mammography: longitudinal trends and predictors.
    Carlos RC; Fendrick AM; Abrahamse PH; Dong Q; Patterson SK; Bernstein SJ
    Womens Health Issues; 2005; 15(6):249-57. PubMed ID: 16325138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preferences for colorectal cancer screening strategies: a discrete choice experiment.
    Hol L; de Bekker-Grob EW; van Dam L; Donkers B; Kuipers EJ; Habbema JD; Steyerberg EW; van Leerdam ME; Essink-Bot ML
    Br J Cancer; 2010 Mar; 102(6):972-80. PubMed ID: 20197766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.